Akinosoglou, K.; Rigopoulos, E.-A.; Kaiafa, G.; Daios, S.; Karlafti, E.; Ztriva, E.; Polychronopoulos, G.; Gogos, C.; Savopoulos, C.
Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience. Viruses 2023, 15, 118.
https://doi.org/10.3390/v15010118
AMA Style
Akinosoglou K, Rigopoulos E-A, Kaiafa G, Daios S, Karlafti E, Ztriva E, Polychronopoulos G, Gogos C, Savopoulos C.
Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience. Viruses. 2023; 15(1):118.
https://doi.org/10.3390/v15010118
Chicago/Turabian Style
Akinosoglou, Karolina, Emmanouil-Angelos Rigopoulos, Georgia Kaiafa, Stylianos Daios, Eleni Karlafti, Eleftheria Ztriva, Georgios Polychronopoulos, Charalambos Gogos, and Christos Savopoulos.
2023. "Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience" Viruses 15, no. 1: 118.
https://doi.org/10.3390/v15010118
APA Style
Akinosoglou, K., Rigopoulos, E.-A., Kaiafa, G., Daios, S., Karlafti, E., Ztriva, E., Polychronopoulos, G., Gogos, C., & Savopoulos, C.
(2023). Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience. Viruses, 15(1), 118.
https://doi.org/10.3390/v15010118